Global Tissue Diagnostics Market 2014-2018

Global Tissue Diagnostics Market 2014-2018

Category : Diagnostic and Biotech
Published On : October  2014
Pages : 88



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About Tissue Diagnostics
Tissue diagnostics involve the diagnosis of diseases or analysis of the biological context of the disease by extracting and analyzing the specific tissue context. It has a wide range of applications in clinical diagnostics, clinical research, and cell biology. It is considered as the most accurate and inexpensive technique for diagnosis of diseases such as cancer and inflammatory conditions. In cancer diagnosis, it is widely used for detecting breast cancer, NSCLC, lymphoma, stomach cancer, and prostate cancer. Various technologies such as IHC, ISH, digital pathology, and special staining are used to study the cell. Tissue diagnostics can be carried out by different methods such as FNAC, core biopsy, and open biopsy.
TechNavio's analysts forecast the Global Tissue Diagnostics market to grow at a CAGR of 8.71 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Tissue Diagnostics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of tissue diagnostics technologies, and products including instruments and consumables. In addition, the report includes the revenue generated from use of tissue diagnostics for diagnosis of different types of diseases.
TechNavio's report, the Global Tissue Diagnostics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Tissue Diagnostics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• EMEA        
• APAC
Key Vendors
• Abbott Laboratories
• Agilent Technologies 
• Danaher 
• F. Hoffmann-La Roche 
Other Prominent Vendors
 
• Alere 
• Becton Dickinson and Company
• Bio SB
• Biogenex Laboratories
• bioMérieux
• Cell Signaling Technology
• DiaGenic
• GE Healthcare
• Johnson & Johnson
• Prometheus Laboratories
• Qiagen 
• Sakura Finetek
• Siemens Healthcare
• Sigma-Aldrich 
• Thermo Fisher Scientific

Market Driver
• Increasing Incidences of Cancer
• For a full, detailed list, view our report
Market Challenge
• Highly Competitive Market
• For a full, detailed list, view our report
Market Trend
• Companion Diagnostics 
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Overview
06.1 Applications of Tissue Diagnostics:
07. Place of Tissue Diagnostics in Cancer Detection
07.1 Epidemiology of Cancer
07.2 Causes of Cancer
07.3 Diagnosis of Cancer
07.4 Treatment Methods for Cancer
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09. Market Segmentation by Technology
09.1 Global IHC Market
09.1.1 Market Size and Forecast
09.2 Global ISH Market
09.2.1 Market Size and Forecast
09.3 Global Digital Pathology Market
09.3.1 Market Size and Forecast
09.4 Global Special Staining Market
09.4.1 Market Size and Forecast
10. Market Segmentation by Product Type
10.1 Global Tissue Diagnostics Instruments Market
10.1.1 Market Size and Forecast
10.2 Global Tissue Diagnostics Consumables Market
10.2.1 Market Size and Forecast
11. Market Segmentation by Application
12. Geographical Segmentation
12.1 Tissue Diagnostics Market in Americas
12.1.1 Market Size and Forecast
12.2 Tissue Diagnostics Market in EMEA Region
12.2.1 Market Size and Forecast
12.3 Tissue Diagnostics Market in APAC Region
12.3.1 Market Size and Forecast
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Vendor Analysis 2013
20.3 Other Prominent Vendors
21. Key Vendor Analysis
21.1 Abbott Laboratories
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue
21.1.4 Business Segmentation by Revenue 2011 and 2012
21.1.5 Geographical Segmentation by Revenue
21.1.6 Business Strategy
21.1.7 Key Information
21.1.8 SWOT Analysis
21.2 Agilent Technologies
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation by Revenue 2013
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Developments
21.2.8 SWOT Analysis
21.3 Danaher
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation
21.3.4 Revenue by Business Segmentation
21.3.5 Revenue Comparison 2012 and 2013
21.3.6 Segmentation by Geography
21.3.7 Business Strategy
21.3.8 Key Information
21.3.9 SWOT Analysis
21.4 F. Hoffmann-La Roche
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation
21.4.4 Business Segmentation by Revenue 2012 and 2013
21.4.5 Geographical Segmentation by Revenue
21.4.6 Business Strategy
21.4.7 Key Information
21.4.8 SWOT Analysis
22. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Applications of Tissue Diagnostics
Exhibit 3: Deaths Occurred by Cancer 2012
Exhibit 4: Diagnosis of Cancer
Exhibit 5: Global Tissue Diagnostics Market 2013-2018 (US$ million)
Exhibit 6: Global Tissue Diagnostics Market Segmentation by Technology
Exhibit 7: Global Tissue Diagnostics Market Segmentation by Technology 2013
Exhibit 8: Global IHC Market 2013-2018 (US$ million)
Exhibit 9: Global ISH Market 2013-2018 (US$ million)
Exhibit 10: Global Digital Pathology Market 2013-2018 (US$ million)
Exhibit 11: Global Special Staining Market 2013-2018 (US$ million)
Exhibit 12: Global Tissue Diagnostics Market Segmentation by Technology 2013-2018 (US$ million)
Exhibit 13: Global Tissue Diagnostics Market Segmentation by Technology 2013-2018
Exhibit 14: Global Tissue Diagnostics Market Segmentation by Product Type
Exhibit 15: Global Tissue Diagnostics Market: Segmentation by Product Type 2013
Exhibit 16: Global Tissue Diagnostics Instruments Market 2013-2018 (US$ million)
Exhibit 17: Global Tissue Diagnostics Consumables Market 2013-2018 (US$ million)
Exhibit 18: Global Tissue Diagnostics Market Segmentation by Product Type 2013-2018 (US$ million)
Exhibit 19: Global Tissue Diagnostics Market Segmentation by Product Type 2013-2018
Exhibit 20: Global Tissue Diagnostics Market Segmentation by Disease Type
Exhibit 21: Global Tissue Diagnostics Market: Segmentation by Disease Type 2013
Exhibit 22: Global Tissue Diagnostics Market Segmentation by Geography 2013
Exhibit 23: Tissue Diagnostics Market in Americas 2013-2018 (US$ million)
Exhibit 24: Tissue Diagnostics Market in EMEA Region 2013-2018 (US$ million)
Exhibit 25: Tissue Diagnostics Market in APAC Region 2013-2018 (US$ million)
Exhibit 26: Global Tissue Diagnostics Market Segmentation by Geography 2013-2018 (US$ million)
Exhibit 27: Global Tissue Diagnostics Market Segmentation by Geography 2013-2018
Exhibit 28: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 29: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 30: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 31: Agilent Technologies: Business Segmentation by Revenue 2013
Exhibit 32: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 33: Agilent Technologies: Geographical Segmentation by Revenue 2013
Exhibit 34: Danaher: Business Segmentation
Exhibit 35: Danaher: Business Segmentation 2013
Exhibit 36: Danaher: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 37: Danaher: Revenue by Geographical Segmentation 2013
Exhibit 38: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 39: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 40: F. Hoffmann-La Roche: Revenue of Pharmaceuticals Division by Geography 2013
Exhibit 41: F. Hoffmann-La Roche: Revenue of Diagnostics Division by Geography 2013


Enquiry Before Buy
image
Can´t read the image ? refresh here.